SHUKRA PHARMACEUTICALS LTD.
NSE : NABSE : 524632ISIN
CODE : INE551C01028Industry : Pharmaceuticals & DrugsHouse
: Private
BSE120.642.36 (+2 % )
PREV CLOSE (Rs.) 118.28
OPEN PRICE (Rs.) 120.64
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 509
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE
This Company is not listed in NSE
Company News
| Date | Heading | Details |
|---|---|---|
| 05-Apr-2024 | Shukra Pharmaceuticals informs about disclosure | <div>Shukra Pharmaceuticals has informed that the Shareholders through postal ballot have approved the alteration to clause 5 of the Memorandum of Association (MOA) of the company. And article clause no,3B(ii)(d) of Article of Association(AoA) of the company Accordingly, the MOA of the Company has been altered as follows: The Authorized Share capital of the company is Rs 44,00,00,000 (Rupees Forty-four crore only) consisting of 4,40,0d,000 (Four Crore Forty Lakh) Equity Shares of Rs 10 each.'</div><div><br></div><div>The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
| 05-Apr-2024 | Shukra Pharmaceuticals informs about outcome of postal ballot | <div>Shukra Pharmaceuticals has informed that it enclosed the details of voting results of postal ballot along with the Scrutinizers Report on Postal ballot received and on remote e-voting during the period between Tuesday, March 05, 2024 at 09.00 am (IST) and end on Wednesday, April 03, 2024 at 05.00 pm (IST) (inclusive of both days). The resolution mentioned in the Postal Ballot Notice dated February29, 2024 deemed to be passed on the on the last date specified for voting April 03, 2024.</div><div><br></div><div>The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
| 05-Apr-2024 | Shukra Pharmaceuticals submits scrutinizer's report | <div>Shukra Pharmaceuticals has informed that it enclosed Scrutinizer's Report on Postal Ballot process conducted through electronic voting system in accordance with the provisions of Section 108 and Section 110 and other applicable provisions, if any of the Companies Act, 2013 read with Rule 20 and Rule 22 of Companies (Management and Administration) Rules, 2014, as amended.</div><div><br></div><div>The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
| 29-Feb-2024 | Allotment of Equity Shares | Bonus Issue Inter alia, considered and approved the following items: 1. Issue of Bonus Shares in the proportion of 3: 1i.e. 3 [Three) fully paid-up bonus Equity share of Rs. 10/- [Rupees Ten only) each for every 1 (0ne) I'ully paid-up uity share of Rs. 10/- [Rupees Ten only) each held by the Members of the pany as on the Record Date, subject to approval of Members of the Company rough Postal Ballot. 2. Increase in Authorize share capital of the company from l-2,00,00,000/- [Rupees Twelve Crore to 44,00,00,000/-(Rupees Forty-four Crore) by altering the capital clause of Memorandum of Association of the company subject to approval of Members of the company through Postal Ballot. 3. Amend the Article 38[ii)[d) of Article of Association of the company by altering the capital clause of Article of Association of the company subject to approval of Members of the company through Postal Ballot. 4. Approve the revision in remuneration of Mr. Dakshesh Shah, Chairman Cum Managing Director of the company. 5. Approved postal ballot notice for seeking consent of Members of the Company for the Resolutions as set out in the postal ballot Notice and other matters incidental thereto. |
| 29-Feb-2024 | Notice of Postal Ballot | Bonus Issue Inter alia, considered and approved the following items: 1. Issue of Bonus Shares in the proportion of 3: 1i.e. 3 [Three) fully paid-up bonus Equity share of Rs. 10/- [Rupees Ten only) each for every 1 (0ne) I'ully paid-up uity share of Rs. 10/- [Rupees Ten only) each held by the Members of the pany as on the Record Date, subject to approval of Members of the Company rough Postal Ballot. 2. Increase in Authorize share capital of the company from l-2,00,00,000/- [Rupees Twelve Crore to 44,00,00,000/-(Rupees Forty-four Crore) by altering the capital clause of Memorandum of Association of the company subject to approval of Members of the company through Postal Ballot. 3. Amend the Article 38[ii)[d) of Article of Association of the company by altering the capital clause of Article of Association of the company subject to approval of Members of the company through Postal Ballot. 4. Approve the revision in remuneration of Mr. Dakshesh Shah, Chairman Cum Managing Director of the company. 5. Approved postal ballot notice for seeking consent of Members of the Company for the Resolutions as set out in the postal ballot Notice and other matters incidental thereto. |
| 23-Feb-2024 | Allotment of Equity Shares | Increase in Authorised Capital & Bonus issue Inter alia, to consider and approve :- 1. To consider and approve the proposal for issuance of fully paid up bonus equity shares to the members of the Company subject to necessary approval; 2. To consider and approve the proposal of increase in the authorized share capital of the Company and subsequent alteration to the Memorandum of Association of the Company. if needed, subject to necessary approval; 3. To consider and finalize the matters to be included in Notice of EGM/Postal Ballot including day, Date, Place & Time, if required; |
| 23-Feb-2024 | Bonus Announcement | Increase in Authorised Capital & Bonus issue Inter alia, to consider and approve :- 1. To consider and approve the proposal for issuance of fully paid up bonus equity shares to the members of the Company subject to necessary approval; 2. To consider and approve the proposal of increase in the authorized share capital of the Company and subsequent alteration to the Memorandum of Association of the Company. if needed, subject to necessary approval; 3. To consider and finalize the matters to be included in Notice of EGM/Postal Ballot including day, Date, Place & Time, if required; |
| 28-Nov-2023 | Shukra Pharmaceuticals informs about notice of postal ballot | <div style="text-align: justify;">Pursuant to Regulation 30 and Regulation 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shukra Pharmaceuticals has informed that it enclosed copy of the newspaper clippings for the advertisement published in Business Standard in English Language and Jai Hind in Gujarati language on November 28, 2023, for advertisement matter regarding Notice of Postal Ballot dated November 25, 2023. The Newspaper Advertisements are also available on the website of Company at www.shukrapharmaceuticals.com.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div style="text-align: justify;"><br></div> |
| 13-Oct-2023 | Shukra Pharmaceuticals informs about disclosure | <div style="text-align: justify;">Shukra Pharmaceuticals has informed about Final Demand Notice for payment of First Call Money and/or Second & Final Call Money.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div style="text-align: justify;"><br></div> |
| 07-Oct-2023 | Shukra Pharmaceuticals informs about compliances-certificate | <div style="text-align: justify;">Shukra Pharmaceuticals has enclosed the Certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 by Purva Sharegistry (India), the Registrar and Share Transfer Agent (RTA) of the Company, confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the second quarter ended September 30, 2023.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div> |
